BETA-CASEIN A2 AND REDUCTION OR PREVENTION OF THE SYMPTOMS OF LACTOSE INTOLERANCE

摘要

Described herein is a composition for use in preventing or minimising epigenetic changes to one or more genes responsible for regulating the activity and levels of enzymes involved in digestive processes and gut function in an animal. The composition contains beta-casein. The beta-casein comprises at least 75% by weight of beta-casein variants having proline at position 67 of the beta-casein amino acid sequence.